AH
adi haber
Novocure Ltd
Israel
- Frontiers in Oncology
- Gynecological Oncology
- Research Topics
- PARP inhibitors resistance: new insights in ovarian cancer therapy
PARP inhibitors resistance: new insights in ovarian cancer therapy
3,811
Total downloads
13k
Total views and downloads
34 Authors
- AC
an coosemans
Laboratory of Tumor Immunology and Immunotherapy, Department of Oncology, Leuven Cancer Institute, KU Leuven
Belgium
- EP
eunhyang park
Department of Pathology, Yonsei University College of Medicine
Republic of Korea
- ED
eyal dor-on
Novocure Ltd
Israel
- IV
ignace vergote
Department of Gynecology and Obstetrics, Gynecologic Oncology, Leuven Cancer Institute, KU Leuven
Belgium
- JL
jung-yun lee
Department of Obstetrics and Gynecology, Institute of Women’s Life Medical Science, Yonsei University College of Medicine
Republic of Korea
- KG
ketankumar gajjar
Department of Gynaecological Oncology, Nottingham University Hospitals
United Kingdom
- LC
laetitia collet
Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB)
Belgium
- MG
moshe giladi
Novocure Ltd
Israel
- NC
nicolas chopin
Department of Surgery, Centre Léon Bérard
France
- RW
roxanne wouters
Laboratory of Tumor Immunology and Immunotherapy, Department of Oncology, Leuven Cancer Institute, KU Leuven
Belgium
- SK
sanat kulkarni
Department of Medicine, Sandwell and West Birmingham NHS Trust
United Kingdom
